Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT05167422
Other study ID # 02001055
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date September 14, 2021
Est. completion date July 14, 2023

Study information

Verified date July 2023
Source Dartmouth-Hitchcock Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The objective of this pilot study is to develop and evaluate test a trusted messenger intervention targeting vaccine hesitancy in patients on an inpatient psychiatric hospital setting with both acute and chronic patients.


Recruitment information / eligibility

Status Terminated
Enrollment 2
Est. completion date July 14, 2023
Est. primary completion date July 14, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Able and willing to give verbal informed consent to participate in the study or able to assent with guardian consent - Expected to remain in the hospital for the duration of the study - Mental health diagnosis Demographics - Male, female, or transgender (no exclusion criteria based on gender or sexual orientation) - Ages 18 or older - Any race or ethnicity - English speaking Exclusion Criteria: - Cognitive impairment sufficient to interfere with participant's ability to provide assent - People who are non-English speakers or who have major visual or hearing impairment will be excluded given the need to converse with the Trusted Messenger verbally - People who have received any of the available forms of the COVID-19 vaccine, or those with a medical exemption for receiving the vaccine.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Trusted Messenger
A nested waitlist design in which patients and staff are nested within two inpatient psychiatric units. New Hampshire Hospital staff will be trained to deliver the trusted messenger intervention up to 24 patients on the first unit while the second unit receives care as usual, during which time in-house vaccinations among patients on both units will be tracked in a registry. After a 3-week study period, up to 24 patients on the second unit will receive the trusted messenger intervention and followed for a period of 3 weeks. The trusted messenger intervention will consist of staff who are trained to engage patients informally and assist building social norms for vaccine uptake supported by weekly and as-needed check-ins with a content expert who can answer specific vaccine related questions over a 3 week period.

Locations

Country Name City State
United States New Hampshire Hospital Concord New Hampshire

Sponsors (1)

Lead Sponsor Collaborator
Dartmouth-Hitchcock Medical Center

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Vaccine acceptance- This will be measured using the COVID Vaccine Hesitancy Questionnaire The participant is willing to receive the COVID-19 vaccine Participant is willing to receive the vaccine by the end of week 6 of participation from baseline.
See also
  Status Clinical Trial Phase
Completed NCT05994820 - Chatbot-based Intervention to Promote Vaccine Acceptance in Varansi, India N/A
Completed NCT05537441 - Precision Vaccine Promotion in Underserved Populations N/A
Recruiting NCT05998824 - COVID-19 Vaccination Hesitancy in Adults With Sickle Cell Disease N/A
Completed NCT04939506 - COVID-19 Vaccine Education at the Point of Testing to Increase Vaccine Uptake in Vulnerable Communities in SE Louisiana N/A
Recruiting NCT05787015 - Testing a Personalized Normative Feedback Intervention for Vaccine Hesitancy N/A
Enrolling by invitation NCT06062056 - Motivational Interviewing for Vaccine Uptake in Latinx Adults N/A
Recruiting NCT05473936 - A CHW Intervention to Identify and Decrease Barriers to COVID 19 Testing & Vaccination N/A
Not yet recruiting NCT05531058 - The Impact of a Web-based Psychoeducation Programme With a Motivational AI Chatbot on Covid-19 Vaccine Hesitancy N/A
Not yet recruiting NCT05120817 - Emphasizing the Personal Versus the Social in Educational Interventions For Decreasing Vaccine Hesitancy N/A
Completed NCT05206669 - Testing Messages to Promote HPV Vaccination N/A
Completed NCT06155877 - Testing The Effectiveness Of Two Interventions To Reduce Vaccine Hesitancy Among Adolescents N/A
Completed NCT06124131 - Building Engagement Using Financial Incentives Trial - Colorectal Cancer Screening N/A
Recruiting NCT06417762 - Dime La VerDAD: Verify, Debunk, and Disseminate N/A
Recruiting NCT06297876 - COVIDVaxStories: Randomized Trial to Reduce COVID-19 Vaccine Hesitancy in Populations of Color N/A
Enrolling by invitation NCT06156228 - Multilevel Intervention of COVID-19 Vaccine Uptake Among Latinos N/A
Recruiting NCT05042011 - Role of mHealth-based Interventions Including Social Media to Improve Childhood Immunization Coverage During COVID 19 Pandemic in Pakistan: Qualitative Study
Not yet recruiting NCT06374134 - The Impact of Community and Patient Engagement Practices on Vaccine Confidence in the United States
Completed NCT01385501 - Educational Intervention to Improve Vaccine Acceptance N/A
Completed NCT05582564 - The Effect of Newspaper Reporting on COVID-19 Vaccine Hesitancy: a Randomised Controlled Trial N/A
Completed NCT05390697 - Educational Videos to Address Vaccine Hesitancy in Childhood Immunization N/A